Richard Adcock - Feb 5, 2022 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role: CEO & President, Director
Signature: /s/ Jason Liljestrom, as Attorney-in-Fact
Stock symbol: IBRX
Transactions as of: Feb 5, 2022
Transactions value $: -$158,547
Form type: 4
Date filed: 2/8/2022, 07:53 PM
Previous filing: Oct 8, 2021
Next filing: Mar 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBRX	Common Stock	Options Exercise	$0	+83.3K	+96.7%	$0.00	170K	Feb 5, 2022	Direct	F1
transaction	IBRX	Common Stock	Tax liability	-$159K	-29.4K	-17.35%	$5.39	140K	Feb 5, 2022	Direct	F2
holding	IBRX	Common Stock						1.93K	Feb 5, 2022	See footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IBRX	Restricted Stock Units	Options Exercise	$0	-83.3K	-33.33%	$0.00	167K	Feb 5, 2022	Common Stock	83.3K		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
F2	On February 5, 2022, the Reporting Person's RSUs vested. The RSUs were settled on February 7, 2022, the first business day following the vesting date. The closing price of Immunity Bio, Inc.'s common stock on February 4, 2022 was the settlement price used to calculate the shares withheld.
F3	Shares held by girlfriend living in the same household as the Reporting Person. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F4	Subject to the Reporting Person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021.